XML 51 R30.htm IDEA: XBRL DOCUMENT
v3.24.3

Intangible Assets (Tables) | 12 Months Ended
--- | ---
Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Goodwill |
(In millions) | CooperVision |  | CooperSurgical |  | Total
Balance at October 31, 2023 | $ | 1,747.6 |  |  | $ | 1,876.9 |  |  | $ | 3,624.5 |
Net additions | — |  |  | 157.8 |  |  | 157.8 |
Foreign currency translation adjustment | 50.2 |  |  | 5.9 |  |  | 56.1 |
Balance at October 31, 2024 | $ | 1,797.8 |  |  | $ | 2,040.6 |  |  | $ | 3,838.4 |
Schedule of Finite-Lived Intangible Assets | Other Intangible Assets
| October 31, 2024 |  | October 31, 2023 |  |
(In millions) | Gross Carrying Amount |  | Accumulated Amortization |  | Gross Carrying Amount |  | Accumulated Amortization |  | Weighted-average Amortization Period (in years)
Intangible assets with definite lives: |  |  |  |  |  |  |  |  |
Trademarks | $ | 204.2 |  |  | $ | 90.6 |  |  | $ | 208.9 |  |  | $ | 81.1 |  |  | 15
Composite intangible assets (1) | 1,101.6 |  |  | 496.8 |  |  | 1,061.9 |  |  | 424.8 |  |  | 15
Technology | 706.4 |  |  | 384.3 |  |  | 494.5 |  |  | 335.4 |  |  | 11
Customer relationships | 1,130.5 |  |  | 402.5 |  |  | 1,099.2 |  |  | 345.8 |  |  | 19
License and distribution rights and other | 47.9 |  |  | 27.2 |  |  | 51.6 |  |  | 28.0 |  |  | 11
| 3,190.6 |  |  | $ | 1,401.4 |  |  | 2,916.1 |  |  | $ | 1,215.1 |  |  | 16
Less: accumulated amortization and translation | 1,401.4 |  |  |  |  | 1,215.1 |  |  |  |  |
Intangible assets with definite lives, net | $ | 1,789.2 |  |  |  |  | $ | 1,701.0 |  |  |  |  |
Intangible assets with indefinite lives, net (2) | 1.8 |  |  |  |  | 9.3 |  |  |  |  |
Total other intangibles, net | $ | 1,791.0 |  |  |  |  | $ | 1,710.3 |  |  |  |  |
(1) Composite intangible assets primarily consist of technology, trade name, New Drug Application approval and physician relationships. The components are not reflected separately or within the corresponding categories because they are inextricably linked. (2) Intangible assets with indefinite lives include technology and trademarks.
Schedule of Indefinite-Lived Intangible Assets | Other Intangible Assets
| October 31, 2024 |  | October 31, 2023 |  |
(In millions) | Gross Carrying Amount |  | Accumulated Amortization |  | Gross Carrying Amount |  | Accumulated Amortization |  | Weighted-average Amortization Period (in years)
Intangible assets with definite lives: |  |  |  |  |  |  |  |  |
Trademarks | $ | 204.2 |  |  | $ | 90.6 |  |  | $ | 208.9 |  |  | $ | 81.1 |  |  | 15
Composite intangible assets (1) | 1,101.6 |  |  | 496.8 |  |  | 1,061.9 |  |  | 424.8 |  |  | 15
Technology | 706.4 |  |  | 384.3 |  |  | 494.5 |  |  | 335.4 |  |  | 11
Customer relationships | 1,130.5 |  |  | 402.5 |  |  | 1,099.2 |  |  | 345.8 |  |  | 19
License and distribution rights and other | 47.9 |  |  | 27.2 |  |  | 51.6 |  |  | 28.0 |  |  | 11
| 3,190.6 |  |  | $ | 1,401.4 |  |  | 2,916.1 |  |  | $ | 1,215.1 |  |  | 16
Less: accumulated amortization and translation | 1,401.4 |  |  |  |  | 1,215.1 |  |  |  |  |
Intangible assets with definite lives, net | $ | 1,789.2 |  |  |  |  | $ | 1,701.0 |  |  |  |  |
Intangible assets with indefinite lives, net (2) | 1.8 |  |  |  |  | 9.3 |  |  |  |  |
Total other intangibles, net | $ | 1,791.0 |  |  |  |  | $ | 1,710.3 |  |  |  |  |
(1) Composite intangible assets primarily consist of technology, trade name, New Drug Application approval and physician relationships. The components are not reflected separately or within the corresponding categories because they are inextricably linked. (2) Intangible assets with indefinite lives include technology and trademarks.
Remaining Amortization Expenses for Intangible Assets with Definite Lives | As of October 31, 2024, the estimate of future amortization expenses for intangible assets with definite lives is as follows:
Fiscal years: | (In millions)
2025 | $ | 197.7 |
2026 | 190.1 |
2027 | 175.8 |
2028 | 171.3 |
2029 | 167.2 |
Thereafter | 887.1 |
Total remaining amortization for intangible assets with definite lives | $ | 1,789.2 |

X
- Definition Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 55 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 55 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration